through a Steering Committee, a two day workshop in order to see whether workers in Britain in the field of dementia research, could agree on guidelines for the minimum data which should be collected, in clinical and pathological studies on patients with presumed Alzheimer's disease (AD) and dementia.
A report from this workshop is available from the Medical Research Council.' The purpose of this article is to summarise this report and to compare it with other approaches. There have been, broadly, two kinds of solution to the problem of standardisation for research comparison: the first is to use research diagnostic criteria; the second is to use a standardised assessment schedule. There are advantages and disadvantages to each of these solutions.
Research diagnostic criteria The use of research diagnostic criteria entails the specification of those criteria which must be fulfilled if the diagnosis of Alzheimer's disease is to be made. Research subjects can be divided, by means of these criteria, into those who have Alzheimer's disease and those who do not. Some advantages of this approach are : (i) A definition of the condition (Alzheimer's disease) is specified.
(ii) Research can be directly compared in that all subjects fulfil the criteria. (iii) The applicability of any conclusions from the research is relatively clear-cut in the sense that the results pertain to a specific and defined population. Two important examples of this approach are the report of the NINCDS-ADRDA Work Group2; and Standardised assessment schedules The use of assessment schedules entails the specification of the information which should be collected, and the method by which this should be done. The advantages of this approach are: (1) It does not impose a definition of the condition. This allows for flexibility amongst research workers as to which subjects are included in a study. (2) Despite this flexibility, research workers can compare subjects because the same data has been collected in the same way. (3) Sub-groups of subjects can be identified and compared post-hoc as long as the sub-groups can be defined with reference to the standardised assessment procedure. (4) Research workers are more likely to agree on the information which should be collected than on precise diagnostic criteria.
The main disadvantage of this approach is that no definition of the condition is provided.
Two important examples of standardised assessment schedules relevant to Alzheimer's disease are the Geriatric Mental State (GMS)6 and CAMDEX.7
The MRC Workshop The Steering Committee first identified those who would be asked to participate in the workshop. The range of disciplines represented by the participants was very wide and included psychiatrists, geriatricians, neurologists, neuropathologists, biochemists, psychologists, molecular biologists and immunologists. The Committee asked each of these potential participants to answer those of the following questions which were within their area of competence:
(1) To specify the clinical information required in order to: (a) decide whether a person is suffering from dementia; (b) categorise the degree of dementia; and (c) decide on a clinical diagnosis of the cause of the dementia. (2) To specify the pathological information required in order to be able to make a diagnosis of Alzheimer's disease and multi-infarct dementia.
It was clear from these replies that it would not be possible for participants to agree precise diagnostic criteria at either the clinical or pathological level. The Committee therefore decided that the aim of the workshop should be to provide guidelines for the minimum data which should be collected in clinical and pathological studies on patients with presumed Alzheimer's disease and dementia. On the basis of the answers to the above questions, the Committee drew up a proposal as to what these minimum data should be. In drawing this up there were two guiding principles. Firstly, the proposals should be as brief as possible so as not to burden research workers with an excess of data to be collected; and, secondly that the data to be collected should be specified as precisely as possible, so as to maximise the comparability between different research workers.
Recommended minimum data to be collected in research studies on Alzheimer's disease
The Steering Committee's proposal was sent to all participants prior to the workshop. The workshop provided the opportunity for all participants to criticise and suggest alterations to the Steering Committee's proposal. Each session was devoted to one section of the proposal. The points made by participants were incorporated into a revised version and this revised version was reconsidered by the workshop. Further alterations were made until participants agreed to a final version. The workshop reached agreement on guidelines for the minimum data which should be collected in clinical and pathological studies of dementia and on the ways in which these guidelines should be applied in the collection of data. These guidelines cover both clinical and neuropathological data.
The workshop's recommendations are considered to constitute the minimum data which should normally be collected. Detailed well validated schedules (for example GMS; CAMDEX) are to be preferred, but it is recognised that these may be too time consuming to be used in all studies.
The guidelines The guidelines specify the information which should be obtained, and the methods and sources which should be used to obtain it. They include a history from an informant, and cognitive, psychiatric and physical examination of the subject. The recommendations endorse the mini-mental state examination8 and include further cognitive items from CAMDEX. In addition, neuropathological information which should be collected (where appropriate) is specified. The guidelines are listed in the Appendix below.
In contrast to the NINCDS-ADRDA Work Group report, these guidelines are not diagnostic criteria but recommendations as to what data should be collected. However, despite this major difference of approach there is considerable agreement about what information should be collected in research studies involving subjects with Alzheimer's disease. Indeed, the information to be gathered under these guidelines should be helpful in the application of diagnostic schemes such as DSM-IIIR, and the NINCDS-ADRDA Work Group.
Review
It is anticipated that the guidelines will be revised in 1989. The MRC would welcome comments and feedback which may help such revision.
We acknowledge the help of all those who replied to the Steering Committee's questions and all the participants. The specific questions proposed originate from a number of sources. Of Since the onset of the problems has he/she said things which suggest that he/she is weary of life or feels that he/she is better off dead?
Since the onset of the problems has he/she said things which suggest that he/she is a failure or that he/she feels guilty or deserves to be punished or that he/she feels that he/she is a bad person?
(xi) Alcohol Did you ever think he/she was a heavy drinker?
(xii) Drugs List of medication taken over the last week.
C Examination of subject (Note date, time of day and place of examinations and any factor which may affect the results ofthis examination independently of the dementia, e.g., has never been fluent in English. fruit.
